Georgios Koutsoudakis

Dr. Georgios Koutsoudakis serves as a Research Fellow at the Barcelona Institute for Global Health (ISGlobal) within the Malaria Immunology group under Prof. Carlota Dobaño and Dr. Gemma Moncunill. With extensive international experience across Germany, Italy, and Spain, his expertise spans molecular and cellular biology, virology, and immunology. His scientific portfolio comprises 33 peer-reviewed publications and contributions to 20 competitive research projects as team member.

His research centers on immunopathology of chronic viral hepatitis (2015-2020) and autoimmune hepatitis (2019-2021), specializing in single-cell T cell repertoire analysis in liver biopsies. Current investigations include immunophenotyping of SARS-CoV-2 responses in healthcare workers, comprehensive T cell profiling in Long Covid, and repertoire analysis in malaria/helminth vaccinated populations. Methodologically, he integrates advanced cellular immunology with clinical virology to decode immune dysregulation mechanisms.

Analysis of his 5 most recent publications reveals dominant focus on T cell dysfunction in viral hepatitis (80% of works), with emerging interest in Covid-19 immunology (20%). Key disciplinary intersections include hepatology-immunology (75%) and infection-vaccinology (25%), consistently employing single-cell resolution techniques across all studies.

Scientific Awards:

• No awards explicitly mentioned in source text

As Co-PI of the FIS PI021/0800 project on autoimmune hepatitis, Dr. Koutsoudakis leads innovative research into T cell repertoire dynamics. His grant participation includes 20 scientific projects (15 non-competitive, 5 competitive) with emphasis on viral hepatitis immunopathology. No student supervision activities are documented in the provided materials.

He actively contributes to the Malaria Immunology group's research infrastructure, developing single-cell analysis pipelines for T cell profiling in infectious disease contexts. Current team initiatives focus on longitudinal immune monitoring in endemic malaria regions and post-Covid immune sequelae, leveraging ISGlobal's Barcelona-based laboratory facilities.